A method for treating demyelinating diseases such as MS comprised of administering to an individual afflicted with a demyelinating disease a medicament that induces prolactin secretion. Prolactin secretion stimulates oligodendrocyte precurser cells, which remyelinate demyelinated nerve cells.
Somewhat further down, there is recognition that MS is a metabolic disease.
http://www.stemcellthera.com/Technology ... ection=488
http://cnrp.marketwire.com/cnrp_files/2 ... 09SSS1.pdf
http://cnrp.marketwire.com/cnrp_files/2 ... 707sss.pdf
http://www.stemcellnetwork.ca/index.php ... =73&hl=eng
Apparently prolactin increases re-myelination and dopamine reduces the amount of prolactin in the body.
Prolactin is also released in men after ejaculation causing a temporary loss of arousal. The more prolactin, the longer the period of time before the man can become aroused again. Unusually high amounts of prolactin are suspected to be responsible for impotence and loss of libido.